Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes
- PMID: 851483
Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes
Abstract
A comparison was made of the esterase and activator activities of the various activated forms of human plasminogen and their streptokinase complexes with Nalpha-Cbz-L-lysine-p-nitrophenyl ester as the substrate. The steady state kinetic properties of Glu- and Lys-plasmins, and Glu- and Lys-plasminogen-streptokinase complexes were identical, while the Lys-plasmin-streptokinase complex showed a 2-fold increase in Km with the same kcat and a 3-fold increase in Ki for the competitive inhibitor leupeptin. Lys-plasminogen (zymogen with an active site) was prepared which incorporated 0.7 mol of [3H]idisopropyl phosphorofluoridate and 0.43 mol of p-nitrophenyl-p'-guanidinobenzoate/mol of protein. The Km for Lys-plasminogen was 3-fold higher than that of Lys-plasmin, and its maximum velocity 10-fold lower. The steady state kinetic parameters of a plasmin-derived light (B) chain (CmCys)3, and a derived equimolar light (B) chain-streptokinase complex (CmCys)3, isolated from human plasmin and equimolar plasmin-streptokinase, or plasminogen-streptokinase, complexes, respectively, were determined. When the light (B) chain-streptokinase complex is isolated from its parent complexes, there is a complete retention of the original parent's esterase activities, with respect to Km and kcat, and interaction with the competitive inhibitors benzamidine and leupeptin. The plasmin-derived light (B) chain does not retain its parent esterase activities. This chain has very similar kinetic properties to Lys-plasminogen except that streptokinase, in an equal molar amount, does not impart full esterase activity to the light (B) chain whereas the zymogen can be completely activated by streptokinase. The kcat of the plasmin-derived light (B) chain, and its streptokinase complex can be enhanced by 50 and 30%, respectively, in the presence of 10(-4) M leupeptin, a competitive inhibitor of plasmin, attesting to the increased structural flexibility within the active site of this enzyme species. Urokinase hydrolyzes Nalpha-Cbz-L-lysine p-nitrophenyl ester efficiently with a kcat/Km of one-third that of plasmin. The human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes were compared in a kinetic assay. The Lys-plasmin-streptokinase complex, and streptokinase were the least active of the activator species and were approximately equal in their activator activities. Glu- and Lys-plasminogen-streptokinase complexes had approximately 1.5 times the activity of streptokinase, whereas the equimolar light (B) chain-streptokinase complexes had approximately 2- to 3-times the activator activity of streptokinase. Since the esterase activity remained unchanged, this indicates a greater degree of specificity in the active site of the equimolar light (B) chain-streptokinase activator complex. Urokinase proved to be a poor activator species...
Similar articles
-
Isolation of a human plasmin-derived, functionally active, light (B) chain capable of forming with streptokinase an equimolar light (B) chain-streptokinase complex with plasminogen activator activity.J Biol Chem. 1976 Sep 25;251(18):5810-13. J Biol Chem. 1976. PMID: 134997
-
Comparative activation kinetics of mammalian plasminogens.Biochim Biophys Acta. 1983 May 30;745(1):20-31. doi: 10.1016/0167-4838(83)90165-6. Biochim Biophys Acta. 1983. PMID: 6682680
-
Activation of human and bovine plasminogens by the microplasmin and streptokinase complex.Thromb Res. 1990 May 1;58(3):317-29. doi: 10.1016/0049-3848(90)90101-h. Thromb Res. 1990. PMID: 2141198
-
Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.Drugs. 1987;33 Suppl 3:33-50. doi: 10.2165/00003495-198700333-00005. Drugs. 1987. PMID: 3315613 Review.
-
Species specificity of streptokinase.Comp Biochem Physiol B. 1983;75(3):389-94. doi: 10.1016/0305-0491(83)90345-0. Comp Biochem Physiol B. 1983. PMID: 6349918 Review.
Cited by
-
The human plasma fibrinolytic system: regulation and control.Mol Cell Biochem. 1978 Aug 16;20(3):149-57. doi: 10.1007/BF00243761. Mol Cell Biochem. 1978. PMID: 151804 Review.
-
Effect of desialylation on the biological properties of human plasminogen.Biochem J. 1992 May 15;284 ( Pt 1)(Pt 1):81-6. doi: 10.1042/bj2840081. Biochem J. 1992. PMID: 1599413 Free PMC article.
-
Breaching the conformational integrity of the catalytic triad of the serine protease plasmin: localized disruption of a side chain of His-603 strongly inhibits the amidolytic activity of human plasmin.Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5374-7. doi: 10.1073/pnas.90.11.5374. Proc Natl Acad Sci U S A. 1993. PMID: 8506386 Free PMC article.
-
[The enzymatic linkage of fibrinogenesis and fibrinolysis (author's transl)].Klin Wochenschr. 1978 Aug 15;56(16):781-8. doi: 10.1007/BF01489710. Klin Wochenschr. 1978. PMID: 211314 Review. German.
-
Function of streptokinase fragments in plasminogen activation.Biochem J. 1994 Nov 15;304 ( Pt 1)(Pt 1):235-41. doi: 10.1042/bj3040235. Biochem J. 1994. PMID: 7998939 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources